U.S. military personnel at greater risk for skin cancer than general population

When one considers the risks of military service, skin cancer may not be top of mind. According to research published in the Journal of the American Academy of Dermatology, however, U.S. military personnel are more likely to develop skin cancer than the general population.

A review of nine published studies indicates that both active duty service members and veterans have an increased risk of developing skin cancer, including melanoma, the deadliest form of skin cancer. According to the authors, the military's demographics include two groups known to have high rates of skin cancer: Caucasians and men over 50. Additionally, military personnel are often exposed to high levels of ultraviolet radiation, which can increase one's risk for both melanoma and nonmelanoma skin cancer.

"From the Pacific Theater in World War II to more recent campaigns in Iraq and Afghanistan, U.S. military members have been deployed to areas where they face prolonged exposure to the sun's harmful UV rays," says board-certified dermatologist Jennifer G. Powers, MD, FAAD, one of the authors of the JAAD article. "This exposure is even more intense for those serving in desert environments because the sun's rays reflect off of sand."

As the JAAD review and an accompanying commentary indicate, the risk of skin cancer among military personnel is further compounded because sun protection is not a priority among active duty service members. And for many soldiers, skin cancer prevention strategies -; like wearing protective clothing that is not part of their uniform, or carrying and applying sunscreen -; are simply not feasible during deployment.

"U.S. military personnel face a unique set of skin cancer risk factors," says Oliver J. Wisco, DO, FAAD, one of the authors of the commentary. "While they may not be able to take steps to reduce their risk during their deployment, they can take steps to detect skin cancer early, when it's most treatable."

The American Academy of Dermatology encourages everyone to perform regular self-exams to check themselves for signs of skin cancer, asking a partner to help them examine hard-to-see areas like their back. Those who notice any new or suspicious spots on their skin, or any spots that are changing, itching or bleeding should see a board-certified dermatologist.

"During Skin Cancer Awareness Month in May, the AAD is recognizing Skin Cancer Heroes, and that of course includes the heroes of the U.S. military," says board-certified dermatologist Suzanne M. Olbricht, MD, FAAD, president of the AAD. "We encourage our soldiers and veterans to be aware of their increased skin cancer risk and be their own Skin Cancer Heroes by regularly examining their skin for suspicious spots."

For more information on skin cancer detection and prevention, visit the AAD website SpotSkinCancer.org. There, you can also find instructions on how to perform a skin self-exam, download a body mole map for tracking changes in your skin and find free SPOTme® skin cancer screenings in your area. SPOT Skin Cancer is the AAD's campaign to create a world without skin cancer through public awareness, community outreach programs and services, and advocacy that promote the prevention, detection and care of skin cancer.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Global study reveals shifting trends in ovarian cancer incidence by subtype and region